Catalyst Wire Dossier Catalyst Wire Dossier

Viekira Pak

glecaprevir/pibrentasvir or ombitasvir/paritaprevir/ritonavir/dasabuvir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Viekira Pak, covering 2021-11-05 to 2021-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C [Phase 4]

See pricing